SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001493152-24-006882
Filing Date
2024-02-15
Accepted
2024-02-15 16:54:45
Documents
16

Document Format Files

Seq Description Document Type Size
1 formf-1.htm F-1 5192517
2 ex4-2.htm EX-4.2 676864
3 ex4-3.htm EX-4.3 59374
4 ex5-1.htm EX-5.1 29012
5 ex23-1.htm EX-23.1 3313
6 ex23-2.htm EX-23.2 903
7 ex23-3.htm EX-23.3 3046
8 ex23-4.htm EX-23.4 6391
9 ex107.htm EX-FILING FEES 24785
10 formf-1_001.jpg GRAPHIC 14014
11 formf-1_002.jpg GRAPHIC 23690
12 formf-1_003.jpg GRAPHIC 23660
13 ex4-2_001.jpg GRAPHIC 2403
14 ex4-2_002.jpg GRAPHIC 2027
15 ex23-2_001.jpg GRAPHIC 130800
16 ex5-1_001.jpg GRAPHIC 3576
  Complete submission text file 0001493152-24-006882.txt   6273885
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-277115 | Film No.: 24644591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)